A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions: Overweight; Obesity Interventions: Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg; Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg; Drug: SIB Group Sibus (Sibutramine) 15mg; Drug: Placebo Group Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials